By Destiny Obinna
The National Agency for Food and Drug Administration and Control (NAFDAC) has recorded major regulatory achievements in 2026, including the destruction of unwholesome products worth N22.73 billion, 821 product seizures and 52 arrests in an intensified crackdown on unsafe and substandard products.
The agency also disclosed that more than 70 per cent of finished pharmaceutical products covered by its 5+5 policy and Ceiling 36 are now manufactured locally, in a major boost to Nigeria’s drive for pharmaceutical self-sufficiency and medicine security.
The achievements, recorded amid efforts to strengthen regulatory systems, digital innovation and local manufacturing, were presented at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19, 2026.
NAFDAC’s regulatory update also highlighted its sustained World Health Organisation (WHO) Maturity Level 3 status and ongoing transition towards Maturity Level 4, the highest level of the WHO Global Benchmarking Tool.
According to the agency, its enforcement activities between January and August 2026 included 5,542 enforcement operations, 213 raids, 821 product seizures, closure of 179 premises, 52 arrests and 221 sanctions.
It also conducted 22 destruction exercises involving unwholesome products valued at approximately N22.73 billion.
The agency said the enforcement drive was part of efforts to protect Nigerians from substandard and falsified medicines, unsafe food and other regulated products.
On pharmaceutical manufacturing, NAFDAC said its 5+5 policy was yielding results, with more than 70 per cent of finished pharmaceutical products under the policy and Ceiling 36 now being manufactured locally.
The initiative is designed to reduce dependence on imported medicines, encourage domestic pharmaceutical investment and strengthen the country’s capacity to meet its healthcare needs.
The agency also identified digital transformation as a major pillar of its regulatory reforms, listing the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), GMP Inspection (GMPi), Application and AI-assisted Technical Screening Tools (TST), and the revised Med Safety App among initiatives supporting its regulatory operations.
The revised Med Safety App is expected to strengthen reporting of adverse drug reactions and substandard and falsified medical products.
In another milestone, NAFDAC said its growing regulatory capacity had positioned Nigeria as a reference National Regulatory Authority in Africa, with Uganda, The Gambia, Mozambique and Côte d’Ivoire among countries whose regulatory authorities had visited the agency for technical capacity building and institutional benchmarking.
Nigeria also ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on October 25, 2026, further strengthening its participation in efforts to harmonise medicines regulation across the continent.
The agency attributed the milestones to the strategic leadership of its Director-General, Prof. Mojisola Christianah Adeyeye, whose administration has prioritised institutional transformation, science-based regulation, digital innovation and international cooperation.
NAFDAC said the achievements underscored its commitment to strengthening regulatory capacity, protecting public health and positioning Nigeria as a leading regulatory authority in Africa.
